267 related articles for article (PubMed ID: 18372605)
1. [Influence of long-term intake of proton pump inhibitors on gastric mucosa and neuroendocrine system of gastric secretion regulation in patients with acid-dependent diseases].
Rapoport SI; Khutsishvili MB; Rasulov MI; Trubitsina IE; Raĭkhlin NT
Ter Arkh; 2008; 80(2):86-9. PubMed ID: 18372605
[No Abstract] [Full Text] [Related]
2. Control of gastric acid secretion in health and disease.
Schubert ML; Peura DA
Gastroenterology; 2008 Jun; 134(7):1842-60. PubMed ID: 18474247
[TBL] [Abstract][Full Text] [Related]
3. [Acid secretory rebound after gastric antisecretory treatment. Above all, a problem for the physiologists!].
Vallot T; Mignon M
Gastroenterol Clin Biol; 1994; 18(8-9):677-9. PubMed ID: 7875433
[No Abstract] [Full Text] [Related]
4. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.
Jensen RT
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):4-19. PubMed ID: 16433886
[TBL] [Abstract][Full Text] [Related]
5. Intragastric pH with oral vs intravenous bolus plus infusion proton-pump inhibitor therapy in patients with bleeding ulcers.
Laine L; Shah A; Bemanian S
Gastroenterology; 2008 Jun; 134(7):1836-41. PubMed ID: 18423628
[TBL] [Abstract][Full Text] [Related]
6. Impact of acid-related disorders in the United States.
Brown M; Yang RD
Manag Care; 2001 Oct; 10(10 Suppl):7-10. PubMed ID: 11729446
[TBL] [Abstract][Full Text] [Related]
7. [Prolonged therapy with proton pump inhibitors: balance of benefits and risks].
Lazebnik LB; Bordin DS; Masharova AA
Eksp Klin Gastroenterol; 2010; (9):3-8. PubMed ID: 21427916
[No Abstract] [Full Text] [Related]
8. [Protection of the gastric mucosa by prostaglandins--is this physiologic concept suitable for ulcer therapy?].
Schepp W
Leber Magen Darm; 1986 Jan; 16(1):41-50. PubMed ID: 3959724
[No Abstract] [Full Text] [Related]
9. Efficacy and safety of herbal medicines in treating gastric ulcer: a review.
Bi WP; Man HB; Man MQ
World J Gastroenterol; 2014 Dec; 20(45):17020-8. PubMed ID: 25493014
[TBL] [Abstract][Full Text] [Related]
10. [Histomorphological changes of gastric mucosa and of some stomach juice components in operated cases of gastric and duedenal ulcer (author's transl)].
Kozak J
Ann Univ Mariae Curie Sklodowska Med; 1973; 28():133-47. PubMed ID: 4789846
[No Abstract] [Full Text] [Related]
11. Pharmacological profile of novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526).
Ito K; Kinoshita K; Tomizawa A; Inaba F; Morikawa-Inomata Y; Makino M; Tabata K; Shibakawa N
J Pharmacol Exp Ther; 2007 Oct; 323(1):308-17. PubMed ID: 17630360
[TBL] [Abstract][Full Text] [Related]
12. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease.
Jang EJ; Park SW; Park JS; Park SJ; Hahm KB; Paik SY; Sin MK; Lee ES; Oh SW; Park CY; Baik HW
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S278-85. PubMed ID: 19120912
[TBL] [Abstract][Full Text] [Related]
13. Intragastric pH with oral versus intravenous bolus plus infusion proton pump inhibitor therapy in patients with bleeding ulcers.
Lin HJ; Tsai JJ
Gastroenterology; 2008 Nov; 135(5):1804-5. PubMed ID: 18840442
[No Abstract] [Full Text] [Related]
14. [Gastric and duodenal ulcers. Gastritis].
Marie-Laure D; Dupas JL
Rev Prat; 2009 Oct; 59(8):1165-9. PubMed ID: 19894464
[No Abstract] [Full Text] [Related]
15. [The sour stomach of the smoker. Protective mechanisms of the mucosa are more important than the level of acid secretion].
Lindell G; Graffner H
Lakartidningen; 1993 Apr; 90(16):1532-4. PubMed ID: 8483349
[No Abstract] [Full Text] [Related]
16. [Effect of inhibitors of gastric secretion on the acid-proteolytic activity of the stomach in ulcer disease].
Gorshkov VA; Nasonova NV
Klin Med (Mosk); 1988 Apr; 66(4):58-62. PubMed ID: 3294498
[No Abstract] [Full Text] [Related]
17. On a possible interrelationship among smoking, gastric ulceration and endogenous prostacyclin.
Balint GA
Exp Toxicol Pathol; 2002 Jul; 54(1):39-41. PubMed ID: 12180800
[TBL] [Abstract][Full Text] [Related]
18. Omeprazole.
Maton PN
N Engl J Med; 1991 Apr; 324(14):965-75. PubMed ID: 2002819
[No Abstract] [Full Text] [Related]
19. [The influence of antisecretory agents on the antral gastric mucosa in patients with duodenal ulcer].
Rapoport SI; Raĭkhlin NT; Khutsishvili MB; Rasulov MI; Antonenko NI
Klin Med (Mosk); 2006; 84(7):32-5. PubMed ID: 16924798
[TBL] [Abstract][Full Text] [Related]
20. [Experimental gastric and duodenal ulcer models: their potential and restrictions].
Trubitsyna IE; Chikunova BZ
Eksp Klin Gastroenterol; 2007; (2):86-92. PubMed ID: 17539351
[No Abstract] [Full Text] [Related]
[Next] [New Search]
